Tspan2: a tetraspanin protein involved in oligodendrogenesis and cancer metastasis. by Yaseen, I.H. et al.
Review Article
Tspan2: a tetraspanin protein involved in
oligodendrogenesis and cancer metastasis
Ibrahim H. Yaseen1, Peter N. Monk2 and Lynda J. Partridge1
1Department of Molecular Biology and Biotechnology, University of Sheffield, Sheffield, U.K. and 2Department of Infection, Immunity and Cardiovascular Diseases, University of
Sheffield Medical School, Sheffield, U.K.
Correspondence: Ibrahim H. Yaseen (ibrahim86_biology@yahoo.com) or (ihyaseen2@sheffield.ac.uk)
Tetraspanin 2 (Tspan2) is one of the less well-characterised members of the tetraspanin
superfamily, and its precise function in different human tissue types remains to be
explored. Initial studies have highlighted its possible association in neuroinﬂammation
and carcinogenesis. In the central nervous system, Tspan2 may contribute to the early
stages of the oligodendrocyte differentiation into myelin-forming glia. Furthermore, in
human lung cancer, Tspan2 could be involved in the progression of the tumour metasta-
sis by modulating cancer cell motility and invasion functions. In this review, we discuss
the available evidence for the potential role of Tspan2 and introduce possible strategies
for disease targeting.
Introduction
Cellular development and pathology are controlled through multiple biological complexes including
transmembrane molecules and their associated partners. Tetraspanins, a superfamily of transmem-
brane proteins of 20–50 kDa, are abundantly expressed and distributed in multicellular organisms and
signiﬁcantly contribute to health and disease. The tetraspanin family is constituted of 33 members in
mammals and retains a highly conserved pattern of amino acid (aa) residues within the family itself,
and in evolution with distantly related species [1]. Since the discovery of the family in 1990, research
conducted on tetraspanins has shown their wide expression in different tissue and cell types, with
most cells expressing several different tetraspanin members [2].
Although interactions with conventional ligands are limited, tetraspanins characteristically interact
laterally with other membrane molecules that may include lipids; such assemblies have been termed
tetraspanin-enriched microdomains (TEMs) [3]. Within TEMs, it has been suggested that tetraspanin
members form direct homologous and heterologous dynamic associations with one another. These
associations can be extended to non-tetraspanin partners including integrins, growth factor receptors,
ectoenzymes and cytoplasmic signalling molecules, giving tetraspanins crucial roles in cellular physi-
ology [4]. The network of interactions of tetraspanins with other membrane proteins, which are often
indirect, has also given rise to the concept of a dynamic compartmentalised ‘web’ on the cell surface
[5]. While such associations were originally imputed from co-immunoprecipitation experiments [3],
some direct interactions between tetraspanins and their partners have been veriﬁed by covalent cross-
linking and the biophysical properties of TEM are being characterised by high-resolution microscopy
techniques. Recent investigations on the molecular organisation of individual tetraspanins in plasma
membrane sheets using dual-colour STED microscopy have, in fact, challenged the view that TEMs
contain multiple different tetraspanins [6]. These studies suggested that tetraspanins are arranged in
clusters of ∼120 nm containing <10 molecules of a particular tetraspanin and that while some tetra-
spanins partially co-localise, others appear as clusters of a single tetraspanin type. Moreover, while
clusters of individual tetraspanins were relatively close or adjacent in the membrane, non-tetraspanin
partner proteins were in even closer proximity [6].
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While the precise molecular functions of tetraspanins are still largely conjectured, the family appears to gen-
erally be involved in regulating the membrane expression, trafﬁcking and spatial organisation of the partner
molecules they associate with in cell membranes [5]. For example, members of the TspanC8 subgroup regulate
the maturation and ER exit of the ADAM10 metalloprotease [7,8], and different TspanC8 members may regu-
late its activity [9]. Therefore, tetraspanins have been implicated in many diverse biological pathways and
functions including cell migration and adhesion, cell:cell fusion, tumour progression and metastasis, infection
and immune response activation [5].
Interestingly, tetraspanins are also enriched on extracellular vesicles (EVs) such as exosomes. These vesicles
are small in size (30–120 nm) and allow the transfer of biologically active molecules between cells, facilitating
intercellular communication, and tetraspanins have been implicated in their formation and function [10,11].
Studies on some tetraspanin knockout mice have yielded important information. While female mice lacking
CD9 show greatly reduced fertility due to a defect preventing oocyte fusion with sperm (reviewed in ref. [12]),
other tetraspanin knockout mice initially showed few obvious phenotypes at the whole-organism level. Closer
analysis of such animals, however, has revealed changes in cell behaviour that affect biological processes; for
example, apparently healthy CD37−/− mice show impaired cellular immunity due to changes in dendritic cell
migration [13].
Nevertheless, although certain tetraspanins (mainly those of the CD group) have received considerable atten-
tion, details about the biological characteristics of a relatively high proportion of these proteins are currently
lacking and some members have been little characterised at the protein level. This is in part due to the lack of
speciﬁc antibodies against the native form of the molecule. This review focuses on one such tetraspanin 2,
Tspan2. The known properties of Tspan2 will be described along with studies that shed light on the emerging
functions of this tetraspanin, with emphasis on its associations with oligodendrogenesis and tumour
progression.
Tetraspanin structure
Tetraspanins cross the membrane four times through hydrophobic transmembrane (TM1–4) domains, forming
two differently sized extracellular loops, one small intracellular loop (∼4 aa), and N- and C-cytosolic stretches
that are typically short (4–19 aa), although some are longer. The TM regions contain conserved polar residues,
which appear to be important for conformational stability and have been suggested to be involved in interac-
tions between the TM helices [14]. Palmitoylation of several cytoplasmic proximal cysteines of the TM
domains has been demonstrated, and palmitoylation appears to be important for microdomain organisation
and interactions between tetraspanins and their partner proteins [15,16].
Kitadokoro et al. reported the 3D structure of the large extracellular domain 2 (EC2) of CD81, and until
recently, detailed structural analysis and molecular modelling have concentrated on this region [17–19]. These
studies have shown that the EC2 can be delineated into two regions: a conserved domain consisting of three
alpha helices, two of which form a ‘stalk’ adjoining TM3 and TM4, and a variable subdomain, forming part of
the ‘head’ region. Molecular modelling suggested that the ﬁrst small extracellular loop (13–30 aa) is likely to be
shaded by the mushroom-shaped EC2 (70–130 aa). The distinctive variable regions are predicted to be respon-
sible for protein-speciﬁc interactions [19–21]. The EC2 contains 4–8 cysteines, including a conserved CCG
‘signature’ motif, which forms at least two disulphide bridges that stabilise the head region. Most monoclonal
antibodies (mAbs) capable of recognising native tetraspanins bind to this region [22]. Recombinant versions of
the EC2 appear to fold correctly and have been shown to exhibit biological activity in many systems [23].
Cryo-electron microscopy of tetraspanin uroplakin complexes, naturally present on bladder epithelium, indi-
cated a rod-like structure, with the four TM helices closely packed and involved in interacting with their
partner proteins, as well as the EC2s [24]. Strikingly, however, the full-length CD81 structure published very
recently by Zimmerman et al. [25] indicates that the transmembrane domains occur as two quite separate
paired helices, with a distinct hydrophobic cavity that can accommodate bound cholesterol. Interestingly, polar
residues in TM1 and TM4 formed hydrogen bonds with cholesterol. Moreover, molecular simulations suggest
that the CD81 EC2 may adopt an ‘open’ conformation above the TM regions when cholesterol is dissociated
from the TM pocket and a ‘closed’ conformation, closer to the TM regions, when cholesterol is present. It is
suggested that cholesterol binding may, therefore, serve to regulate tetraspanin function [25].
While few functions have been ascribed to the N-terminus, the intracellular C-terminal region shows consid-
erable divergence among tetraspanins and can be involved in protein:protein interactions [26,27]. In some
tetraspanins, this region contains a canonical internalisation/lysosomal targeting motif [28], which for CD63
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allows interaction with adaptor protein (AP) complexes and thus clathrin-mediated trafﬁcking. Several tetraspa-
nins also have potential C-terminal PDZ domain-binding sites, CD63 interacts with the PDZ domain of synte-
nin [29] and CD81 interacts with the EBP50 and Sap97 proteins that are expressed in the developing rat retina
[30]. The reported associations with the C-terminus include that of CD81 with ezrin–radixin–moesin (ERM)
proteins [31] and Rac1 GTPase [32]. Mainly from co-immunoprecipitation studies, associations with intracellu-
lar signalling proteins including activated protein kinase C (PKC) [33], type-II phosphatidylinositol 4-kinase
[34], an isoform of the 14-3-3 a serine-/threonine-binding protein [35] and heterotrimeric G proteins [36] have
also been described.
Tetraspanins and cancer metastasis
Notably, across several types of human cancer, tetraspanins appear to play roles in tumour initiation, enhanced
migration, invasion and resistance to drugs; this promotes successful metastasis [37]. This is perhaps not sur-
prising, as TEMs may include and regulate several classes of key molecules, such as integrins and metallopro-
teases, which are essential in carcinogenesis and tumour progression. CD151 expression, in particular, is
positively associated with various stages of cancer progression and supports de novo tumorigenesis in mouse
models (Hemler [37]). The association of CD151 with various integrin partners and modulation of their activ-
ity (e.g. α6β4 integrin in squamous cell carcinoma [38] and α6β1 in hepatocellular carcinoma [39]) have been
shown to be important in this regard. Matrix metalloproteinase (MMP) expression and activity, also regulated
via CD151 within TEMs, may also participate in the progression of some malignancies (e.g. MMP-7 and
MMP-9 in melanoma cell invasiveness [40,41]). There is also evidence that tumour-derived exosomes contain-
ing CD151 (and Tspan8) initiate active epithelial–mesenchymal transition (EMT) and metastasis progression in
pancreatic carcinogenesis [42].
While some tetraspanin proteins promote tumour progression, others suppress cellular metastatic activity in
the same tissue. Notably, tetraspanin CD82 has long been described as a metastasis suppressor, and expression
of CD82 generally correlates with reduced cell motility and invasiveness (reviewed in ref. [43]). Evidence for
the association of other tetraspanins with cancer progression is more mixed and may depend on the particular
cancer and constitution of the TEMs therein. For example, expression of CD9 is associated with better progno-
sis in a range of cancers [44]; however, increased expression of CD9 was increased in advanced gastric cancer
[45] and ovarian cancer [46]. Moreover, CD9 overexpression in human ﬁbrosarcoma cells promoted invasive-
ness and secretion of MMP-9 [47], while CD9 knockdown reduced invasiveness and metastasis of human
breast cancer cell models in vitro and in vivo [48]. Similarly, in glioblastoma, where high CD9 expression corre-
lates with poor patient survival, CD9 silencing reduced behaviour associated with malignancy in glioblastoma
stem cell lines in vitro and in vivo [49].
In contrast, reduced expression of the structurally related tetraspanin CD81 correlates with worse survival in
hepatocellular carcinoma [50] and bladder cancer [51]. CD81 expression also correlates with a reduction in
cellular activities associated with invasiveness in models of gastric cancer [52] and hepatocarcinoma [53] and
promotion of cytostasis in glioma [54]. However, overexpression of CD81 promoted cell motility and increased
invasiveness in melanoma cell lines through the up-regulation of metalloprotease MTI-MMP [55]. Recent
evidence has also shown that primary tumour growth and metastasis are impaired in CD81 knockout mice,
due to functional impairment of myeloid-derived suppressor cells and T regulatory (Treg) cells that otherwise
promote tumour cell escape from anti-tumour immune responses [56].
Tspan2 discovery and general characteristics
Tspan2 was ﬁrst identiﬁed in 1998 by Todd et al., who interrogated the EST database with a tetraspanin con-
sensus sequence, resulting in the discovery of six new tetraspanins (Tspan1–Tspan6), which were subsequently
sequenced from human cDNA [57]. Rat Tspan2, which has >90% homology with human Tspan2, was identi-
ﬁed shortly afterwards from an oligodendrocyte cDNA library and shown to be strongly expressed at the
mRNA level during oligodendrocyte differentiation [58].
The human Tspan2 protein is encoded by the TSPAN2 gene, also known as NET3, TSN2, TSPAN-2 and
FLJ12082, which is located on chromosome 1p13.2 (Ensembl gene accession ID: ENSG00000134198) [59,60].
Although four mRNA splice variants are annotated for the TSPAN2 gene in the genomic interpretation system
Ensembl, three are protein-coding variants and only one of them (Ensemble transcript ID: ENST00000369516)
represents the full-length Tspan2 protein [59]. According to UniProt (UniProtKB – O60636) sequence analysis
and protein topology prediction, Tspan2 protein consists of 221 aa, of which 77 aa form the EC2 containing
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the CCG motif. The EC2 is predicted to contain two disulphide bridges between a total of four cysteine mole-
cules (see Figure 1).
The cytoplasmic N- and C-terminal regions are predicted to be 13 and 12 aa, respectively, and the latter has
a potential PDZ-binding motif class III (RDVI). As with other tetraspanins, Tspan2 is potentially palmitoylated
at the membrane-proximal cysteines. Tspan2 is predicted to be N-glycosylated at asparagine 139 and shares a
relatively high sequence homology with both CD9 and CD81, represented by aa identities of 46.7 and 41%,
respectively. The EC2 region, however, shows greater divergence, and here Tspan2 has residue identities of 31
and 29% with the EC2s of CD9 EC2 and CD81 EC2, respectively [61–63]. Furthermore, genomic analysis of
the tetraspanin orthologue groups, such as Tspan2/CD9/CD81, suggests functional relatedness between these
groups (see Figure 2) [1].
In the rat, Tspan2 mRNA expression was reported to be restricted to the nervous system [58]. However,
Tspan2 clones were isolated from human libraries derived from the foetal heart, T cells and pregnant uterus
[57]. Expression by various lymphoid and non-lymphoid carcinoma cell lines has been described at the mRNA
level [64], and information from online databases also indicates a fairly wide tissue expression. Preliminary
studies by our group using anti-Tspan2 monoclonal antibodies also suggest that the protein is expressed quite
widely in a variety of human tissues and cell lines.
Possible functions of Tspan2
The main functions so far attributed to Tspan2 are for roles in oligodendrocyte development and cancer metas-
tasis. As mentioned above, Tspan2 appears to be most closely related to the much better characterised CD9
and CD81 proteins, which have been implicated in biological functions related to cell:cell fusion, cell adhesion/
motility and in processes that include the immune response, infection and cancer progression and metastasis.
Figure 1. Prediction of Tspan2 secondary structure.
The predicted disulphide bonds between the CCG motif and the other two cysteines in the EC2 region are highlighted with red colour bonds. The
seven tyrosines are illustrated with yellow colour, whereas the blue colour is the potential glycosylation site at asparagine 139. The aa arrangement
and their topological hydrophobicity/hydrophilicity are extracted from the UniProt database, accession number: UniProtKB— O60636
(TSN2_HUMAN). PM: plasma membrane; EC1: extracellular domain 1; EC2: extracellular domain 2; TM: transmembrane.
468 © 2017 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY-NC-ND).
Biochemical Society Transactions (2017) 45 465–475
DOI: 10.1042/BST20160022
Tspan2 in the nervous system
In the central nervous system (CNS) of invertebrates, the myelin sheath is formed by oligodendrocytes to facili-
tate neurone signal transmission. As mentioned above, Birling et al. reported that rat Tspan2 has a restricted
expression at the mRNA level within the nervous system. The gene was predominantly expressed by cells of the
oligodendrocyte lineage in the developing rat brain, although some expression was still evident in adults.
Immunocytochemistry using an antibody raised against a Tspan2 EC2 peptide conﬁrmed its presence in oligo-
dendrocytes, where it co-localised with myelin basic protein in compact myelin, and also showed labelling of a
Figure 2. Tspan2 protein sequence alignment and dendrogram.
(a) The protein sequence alignment of human Tspan2 along with CD9 and CD81. The bar graph represents the conservation percentages between
each single aa of the concerned tetraspanins. (b) The tree phylogeny of human Tspan2, CD9 and CD81 based on their protein sequence alignment.
The phylogram constructed by the RapidNJ plugin, and the Juke-Cantor evolution model used for distance calculation. Scale bar indicates the
branch length. All the analysis was performed on CLC Sequence Viewer platform version 7.7.1 (QIAGEN, Aarhus, Denmark).
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subpopulation of neurones. Overall, the expression pattern suggested a role for Tspan2 in myelination by the
myelin-forming glia and possibly in the stabilisation of the mature sheath [58]. The tetraspanin CD9 was also
expressed in oligodendrocytes, but had a wider distribution pattern in rat brain and other tissues compared
with Tspan2. In a study aimed at investigating the role of CD9 in oligodendrogenesis, Tspan2 and β1 integrin
along with CD81 were co-immunoprecipitated with CD9 from postnatal rat cerebrum [65]. CD9-deﬁcient
mice, however, showed normal oligodendrogenesis and myelination. This suggests that although CD9 may
assist in the organisation of TEMs in oligodendrocytes, their development could occur in the absence of
CD9 [65].
Interestingly, Tspan2 protein expression is signiﬁcantly increased in the myelin of Plp-knockout mice, a gene
that codes for the proteolipid (PLP) protein which is a major membrane protein component in the CNS
myelin [66]. These mice show axonal pathology similar to that observed in spastic paraplegia type-2 patients,
which are deﬁcient in PLP, but show almost normal myelination. Although not a member of the tetraspanin
superfamily, PLP is a four-span membrane protein that sequesters cholesterol, and it was hypothesised that
Tspan2 might be compensating for its loss in myelin in the Plp-knockout mice. However, TSPAN2 knockout
mice showed normal development and biogenesis of myelin. The mice were also fertile and appeared normal
with respect to motor abilities. Furthermore, mice with double knockout of TSPAN2 and Plp genes showed no
further increase in demyelination and axonal degeneration. However, both single Plp and TSPAN2 knockout
mice showed moderate activation of microglia and astrocytes in the white matter of the brain, and this activa-
tion was strongly increased in the double knockout animals [66]. Overall, this suggests that while Tspan2,
along with PLP, may play a role in regulating neuroinﬂammation, it is not directly involved in myelination.
Microglia belong to the mononuclear phagocyte lineage and it is interesting to note that knockdown/knockout
of CD9 in murine macrophages led to increased activation in response to LPS [67]. In addition, macrophages
from CD9/CD81 double knockout mice showed increased MMP production, and the mice spontaneously
developed pulmonary emphysema [68]. This suggests that these related tetraspanins may generally be involved
in negatively regulating mononuclear phagocyte activation, and it would be interesting to investigate Tspan2
function in other cells of this lineage.
Interestingly, Tspan3 is also expressed on oligodendrocytes and in the myelin sheath and interacts with
oligodendrocyte-speciﬁc protein and β1 integrin to form a complex that may be involved in oligodendrocyte
proliferation and migration [69]. The tetraspanin CD82 has also been associated with oligodendrocyte differen-
tiation and myelination [70]. CD81 is strongly expressed on glial cells in the CNS, and the brains of CD81
knockout mice show increased numbers of astrocytes and microglial cells [71], suggesting a role for this tetra-
spanin in controlling their number. CD81 is up-regulated by astrocytes and microglial cells following spinal
cord injury; an antibody to the tetraspanin, which blocks adhesion and proliferation of microglial cells, was
shown to enhance recovery after spinal cord injury in rats [72]. As mentioned above, CD9 is also expressed in
the CNS and by oligodendrocytes. CD9 is also expressed in the peripheral nervous system and studies using
CD9−/− mice indicate that the tetraspanin is involved in the formation of paranodal junctions and the forma-
tion of compact myelin sheaths [73].
Of note, given the distinct expression of the Tspan2 protein in the CNS, the TSPAN2 gene is suggested to be
involved in migraine disease [74,75]. Analysing >2000 migraine cases through genome-wide association studies
(GWAS), 12 GWAS loci associated with migraine susceptibility have been detected, including a region near
TSPAN2 at 1p13 locus [74]. However, the TSPAN2 gene has not been recognised as one of the high-conﬁdence
genes attributed to migraine disorder, perhaps due to the large distance between TSPAN2 gene and its GWAS
locus [75]. Another large-scale GWAS has identiﬁed 1p13.2 near TSPAN2 as a novel locus that is strongly
suggested to be associated with human stroke related to large artery atherosclerosis disease [76].
Tspan2 and cancer progression
In malignancy, strong expression of Tspan2 is associated with poor prognosis in lung cancer and it has been
linked to disease progression associated with p53 inactivation [77]. Mutation of the tumour suppressor p53 is
often observed in invasive tumours and contributes towards cancer metastasis by modulating EMT [78]. In a
study investigating the contribution of p53 to lung cancer progression, Tspan2 was identiﬁed as being highly
expressed in human small airway epithelial cells (SAECs) knocked down for p53 at both the mRNA and
protein level. Expression of Tspan2 mRNA was also elevated in lung cancer cell lines with p53 mutations.
Knockdown of Tspan2 reduced invasiveness and motility in p53-depleted SAECs or cancer cell lines with p53
mutations, whereas overexpression of Tspan2 enhanced these attributes. Knockdown of Tspan2 was also shown
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to reduce lung metastasis in a mouse model [77]. Co-immunoprecipitation identiﬁed CD44 as one of the pro-
teins interacting with Tspan2 and the role of this protein, which is known to interact with other tetraspanins,
was investigated further. CD44 has been implicated in the cellular response to oxidative stress and CD44
knockdown resulted in increased reactive oxygen species (ROS) production and decreased invasiveness of
SAECs . Knockdown of Tspan2 also caused increased ROS production, whereas its overexpression reduced
ROS production; however, knockdown of CD44 negated this effect. The authors therefore propose that Tspan2
promotes invasiveness in p53-depleted lung cancer cells by binding to CD44 and enhancing its ROS-scavenger
function [77]. It would be interesting, however, to explore further possible effects on some of the other proteins
(MT1-MMP, ADAM-10 and integrins) that were also reported to interact with Tspan2 in these cells.
Proteins that may interact with Tspan2
In addition to the tetraspanins CD9 and CD81, Tspan2 is reported to interact with β1 integrin in oligodendro-
cytes [65] and with CD44, MT1-MMP and ADAM10 in lung cancer cell lines [77]. These interactions were
identiﬁed by immunoprecipitation, albeit in the latter case using stringent detergent, so direct interactions
between Tspan2 and these proteins have not yet been incontrovertibly demonstrated. Associations with these
non-tetraspanin partners have also been described for CD9 and CD81, which are most closely related to
Tspan2 [79–81]. CD9 and CD81 are known to be direct partners of the immunoglobulin superfamily proteins
EWI-2 and EWI-F, which interact with ERM proteins and so can link the tetraspanins to the actin cytoskeleton
[31]. The interactions of CD9 and CD81 with the EWI proteins may be regulated by tetraspanin palmitoylation
[82,83] and involves the EC2 domains and some of the TM regions [84,85]. As mentioned previously, the EC2
region of Tspan2 shows greatest divergence from CD9 and CD81 and as far as we are aware, an interaction
between Tspan2 and the EWI proteins has not been demonstrated, although EWI-2 is strongly expressed in
normal human brain and on astrocytes, but down-regulated in glioblastoma [86]. Notably, immunohistochem-
istry staining of glioma tissue showed high expression of Tspan2 [87].
Interestingly, in a recent study aimed at identifying phosphotyrosine-dependent (pY) protein–protein inter-
actions using yeast two-hybrid analysis, pY-dependent interactions between Tspan2 and the AP growth factor
receptor-bound protein 2 (GRB2) and the regulatory phosphoinositide-3-kinase subunit 3 gamma (PIK3R3)
were identiﬁed [88]. The pY dependence of these interactions was investigated by pull-down experiments in
HEK293 cells. Tspan2 contains seven tyrosines (Figure 1) and mutations of these abrogated the interactions
with GRB2 and PIK3R3. Tyrosine 124 appeared to be critical, as a reversal of the Y124F mutation restored
binding of both proteins and a 15 aa Tspan2 peptide containing Y124-bound puriﬁed GRB2 and PIK3R3.
HEK293 cells overexpressing Tspan2 formed numerous long membrane protrusions and extensive cell:cell
contacts, but this phenotype was greatly reduced for cells expressing Tspan2-Y124F. The interaction between
Tspan2 and GRB2 was conﬁrmed at the plasma membrane by YFP-based complementation, whereas the inter-
action with PIK3R3 was mainly cytoplasmic [88].
Phosphorylation of Tspan2 has not been directly shown in vivo; however, and since Y124 is in the putative
extracellular EC2 domain of Tspan2, the role for phosphorylation here in cell signalling is unclear.
Nevertheless, phosphoproteomics data indicate that a large number of tetraspanins may be phosphorylated
[89,90], and of interest, Tspan8 is described as being phosphorylated at position Y122 [91], which corresponds
to Y124 in Tspan2 (and Y125 in CD9, which can be phosphorylated experimentally [90]). Although tyrosine
phosphorylation associated with cell signalling is generally assumed to be mediated by kinases that act intracel-
lularly, it is also worth noting that the properties of secreted tyrosine kinases that act extracellularly have
recently been described [92–94].
Conclusion and future prospects
The diversity of tetraspanin biology is expanding as the ﬁeld moves on, and more discoveries relating to
member-speciﬁc mechanisms of functions are to be made. Tspan2, as one of the more recently discovered
tetraspanins, introduces new questions about the key role it may play, especially in CNS development and car-
cinogenesis. In malignancy, studies on Tspan2 have revealed characteristics that may explain its involvement in
tumour invasiveness and metastasis including human lung adenocarcinomas [77]. In addition, a link has been
established through GWAS to a potential association of Tspan2 with a migraine in humans, although further
studies are required here. Understanding the differential expression of Tspan2, particularly in the oligodendro-
cyte lineage, may also identify targets for future therapies in neurodegenerative diseases.
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As with the other tetraspanin molecules, Tspan2 may modulate some pathophysiological conditions and has
very recently been proposed to be involved in diabetes [95]. At high glucose concentrations, Tspan2 appeared
to induce apoptosis of a human pancreatic β-cell line by modulating the JNK/β-catenin signalling pathway,
suggesting a potential therapeutic approach against the glucotoxic apoptosis in diabetes [95]. The TSPAN2
gene locus has also recently been identiﬁed as a risk factor for ischaemic stroke [96]. Interestingly, recent
unpublished data from our laboratory indicate a role for Tspan2 in the secretion of EVs by some cancer cell
lines. Altogether this suggests that Tspan2 may constitute a target in various disease conditions.
Strategies for developing cell-speciﬁc reagents are essential to avoid the unfavourable consequences when
targeting Tspan2. Monoclonal antibodies against the native form of Tspan2 are valuable tools that would intro-
duce wide treatment options where applicable. Peptides representing the EC2 offer an alternative strategy to
block or attenuate Tspan2 activity, as would strategies to knockdown Tspan2 gene expression.
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